These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 3378854
1. Verapamil pharmacokinetics and liver function in patients with cirrhosis. Finucci GF, Padrini R, Piovan D, Melica E, Merkel C, Gatta A, Zuin R. Int J Clin Pharmacol Res; 1988; 8(2):123-6. PubMed ID: 3378854 [Abstract] [Full Text] [Related]
2. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients. Kawasaki S, Sugiyama Y, Iga T, Hanano M, Sanjo K, Beppu T, Idezuki Y. Am J Gastroenterol; 1985 Oct; 80(10):801-6. PubMed ID: 4036939 [Abstract] [Full Text] [Related]
3. Effect of triglycyl-lysin-vasopressin on quantitative liver function tests in patients with cirrhosis. Merkel C, Bianco S, Bolognesi M, Caregaro L, Amodio P, Sacerdoti D, Gatta A. Am J Gastroenterol; 1992 Nov; 87(11):1580-6. PubMed ID: 1442677 [Abstract] [Full Text] [Related]
4. Effect of somatostatin on liver blood flow and liver metabolic activity in patients with cirrhosis. Merkel C, Gatta A, Caregaro L, Sacerdoti D, Rondana M, Ruol A. Scand J Clin Lab Invest; 1987 Nov; 47(7):667-72. PubMed ID: 2891182 [Abstract] [Full Text] [Related]
5. Hepatic function and portal hemodynamics in patients with liver cirrhosis. Kawasaki T, Moriyasu F, Kimura T, Someda H, Tamada T, Yamashita Y, Ono S, Kajimura K, Hamato N, Okuma M. Am J Gastroenterol; 1990 Sep; 85(9):1160-4. PubMed ID: 2202201 [Abstract] [Full Text] [Related]
6. Effects of verapamil on estimated hepatic blood flow in patients with HBsAg-positive cirrhosis. Lay CS, Tsai YT, Kong CW, Lee FY, Lee SD, Chen KY, Chiang BN, Lo KJ. Hepatogastroenterology; 1988 Jun; 35(3):121-4. PubMed ID: 3402902 [Abstract] [Full Text] [Related]
7. [Theophylline pharmacokinetics in patients with liver diseases with reference to estimated hepatic blood flow]. Nomura F, Ohnishi K, Ohto M, Takeda Y, Rikihisa T, Kanakubo Y. Rinsho Byori; 1991 Oct; 39(10):1093-7. PubMed ID: 1762184 [Abstract] [Full Text] [Related]
12. [Liver metabolism of indocyanine green and aminopyrine in liver cirrhosis: relations with functioning liver cell mass]. Bolognesi M, Merkel C, Angeli P, Caregaro L, Gatta A. Minerva Med; 1988 Dec; 79(12):1035-41. PubMed ID: 3211355 [Abstract] [Full Text] [Related]
13. Decreased splanchnic oxygen uptake and increased systemic oxygen uptake in cirrhosis are normalized after liver transplantation. Tietge UJ, Bahr MJ, Manns MP, Böker KH. Liver Transpl; 2001 Dec; 7(12):1015-22. PubMed ID: 11753903 [Abstract] [Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of dichloroacetate in patients with cirrhosis. Shangraw RE, Fisher DM. Clin Pharmacol Ther; 1999 Oct; 66(4):380-90. PubMed ID: 10546922 [Abstract] [Full Text] [Related]
15. [Determination of hepatic blood flow in chronic liver diseases using the constant infusion technic]. Vorobioff J, Carnovale C, Topol R, Picabea E, Villavicencio R, Tanno H, Audano M, Audano G. Acta Gastroenterol Latinoam; 1984 Oct; 14(3):229-34. PubMed ID: 6537116 [Abstract] [Full Text] [Related]
16. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function. Wensing G, Lotterer E, Link I, Hahn EG, Fleig WE. Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355 [Abstract] [Full Text] [Related]
17. Effects of L-arginine on the systemic, mesenteric, and hepatic circulation in patients with cirrhosis. Kakumitsu S, Shijo H, Yokoyama M, Kim T, Akiyoshi N, Ota K, Kubara K, Okumura M, Inoue K. Hepatology; 1998 Feb; 27(2):377-82. PubMed ID: 9462634 [Abstract] [Full Text] [Related]